ArticleFrontiers in medicine2025
Idiopathic chilblain: a case series from Injibara General Hospital, Ethiopia.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Idiopathic chilblains are inflammatory lesions on the skin that typically appear after being in a cold, wet environment. The condition manifests itself as burning, soreness, and pruritis in the extremities (fingers and toes), usually occurring 12 to 24 h following a triggering event. Conservative measures are the mainstay of treatment for idiopathic chilblain; however pharmaceutical therapy may be necessary in cases that are severe or persistent. This is the only case series in Ethiopia concerning idiopathic chilblain. Case presentation: From June to August of 2024, 12 individuals in the dermatology department of Injibara General Hospital in Ethiopia were diagnosed with idiopathic chilblain. Nine (or 75%) of these patients were women. This study's mean age at diagnosis was 23.2 years (range: 3-55 years). All cases presented with itching sensations and/or pain. Only a few patients presented with swelling and color change during cold exposure. One patient presented with ulceration involving the tip of the digits. Most patients were prescribed clobetasol propionat and oral nifedipine. Others were treated with only topical corticosteroids, and few refused any medical treatment. All patients were counseled to avoid cold and keep extremities warm. Only one patient has persistent disease and the rest have completely improved. Conclusion: According to the current study, young women were the group most frequently impacted by idiopathic chilblain. Idiopathic chilblain in Ethiopia is underreported, necessitating comprehensive studies involving larger patient numbers and a focus on prevalence, diagnosis, treatment, and psychosocial impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.